Adage Capital Partners’s Abeona Therapeutics ABEO Stock Holding History

Adage Capital Partners’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$17.5M	Buy	3,072,985 +381,357	+14%	+$2.17M	0.03%	474
2025 Q1	$12.8M	Sell	2,691,628 -1,210,732	-31%	-$5.76M	0.02%	531
2024 Q4	$21.7M	Buy	3,902,360 +652,366	+20%	+$3.63M	0.04%	424
2024 Q3	$20.5M	Hold	3,249,994	–	–	0.04%	441
2024 Q2	$13.8M	Hold	3,249,994	–	–	0.03%	530
2024 Q1	$23.6M	Hold	3,249,994	–	–	0.04%	405
2023 Q4	$16.3M	Hold	3,249,994	–	–	0.03%	486
2023 Q3	$13.7M	Buy	3,249,994 +1,488,834	+85%	+$6.27M	0.03%	498
2023 Q2	$7.1M	Buy	1,761,160 +430,000	+32%	+$1.73M	0.02%	622
2023 Q1	$3.75M	Hold	1,331,160	–	–	0.01%	735
2022 Q4	$4.1M	Buy	1,331,160 +1,010,870	+316%	+$3.11M	0.01%	767
2022 Q3	$974K	Sell	320,290 -1	-0%	-$3	﹤0.01%	892
2022 Q2	$1.67M	Hold	320,291	–	–	﹤0.01%	891
2022 Q1	$2.52M	Hold	320,291	–	–	﹤0.01%	883
2021 Q4	$2.7M	Hold	320,291	–	–	﹤0.01%	857
2021 Q3	$8.97M	Hold	320,291	–	–	0.02%	720
2021 Q2	$12.5M	Hold	320,291	–	–	0.02%	636
2021 Q1	$15.1M	Sell	320,291 -11,229	-3%	-$528K	0.03%	552
2020 Q4	$13M	Buy	331,520 +111,520	+51%	+$4.38M	0.03%	531
2020 Q3	$5.61M	Hold	220,000	–	–	0.01%	617
2020 Q2	$16M	Hold	220,000	–	–	0.04%	438
2020 Q1	$11.6M	Buy	220,000 +20,000	+10%	+$1.05M	0.03%	436
2019 Q4	$16.4M	Buy	200,000 +80,000	+67%	+$6.54M	0.04%	420
2019 Q3	$6.78M	Hold	120,000	–	–	0.02%	586
2019 Q2	$14.3M	Buy	120,000 +16,000	+15%	+$1.91M	0.04%	440
2019 Q1	$19.1M	Hold	104,000	–	–	0.05%	389
2018 Q4	$18.6M	Buy	104,000 +25,000	+32%	+$4.46M	0.05%	354
2018 Q3	$25.3M	Sell	79,000 -11,000	-12%	-$3.52M	0.06%	353
2018 Q2	$36M	Sell	90,000 -2,558	-3%	-$1.02M	0.08%	274
2018 Q1	$33.2M	Buy	92,558 +9,266	+11%	+$3.32M	0.08%	297
2017 Q4	$33M	Buy	83,292 +3,296	+4%	+$1.31M	0.07%	305
2017 Q3	$34.1M	Buy	79,996 +1,996	+3%	+$851K	0.08%	294
2017 Q2	$12.5M	Hold	78,000	–	–	0.03%	520
2017 Q1	$9.75M	Hold	78,000	–	–	0.02%	541
2016 Q4	$9.46M	Buy	+78,000	New	+$9.46M	0.03%	541